Pharma & Healthcare

Global Peptide Eye Drop Market Research Report 2025

The global market for Peptide Eye Drop was valued at US$ 115 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of 6.9% during the forecast period.
North American market for Peptide Eye Drop is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peptide Eye Drop is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Peptide Eye Drop include Hangzhou Guoguang Pharmaceutical, Jiangsu Hengxin Pharmaceutical, Can-C, Life Extension, Oclumed LLC, OPKO Health, Eyeris Vision Care Pvt. Ltd., Shaanxi Berson Pharmaceutical, Choseido Pharmaceutical, Wuhan Wujing Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peptide Eye Drop, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Eye Drop.
The Peptide Eye Drop market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Eye Drop market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Eye Drop manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hangzhou Guoguang Pharmaceutical
Jiangsu Hengxin Pharmaceutical
Can-C
Life Extension
Oclumed LLC
OPKO Health
Eyeris Vision Care Pvt. Ltd.
Shaanxi Berson Pharmaceutical
Choseido Pharmaceutical
Wuhan Wujing Pharmaceutical
DR Vitamin
Segment by Type
Acetyl Carnosine Eye Drops
Amiodopeptide Eye Drops
Ocular Aminopeptide Eye Drops
Glutathione Eye Drops
Segment by Application
Hospital
Eye Clinic
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peptide Eye Drop manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peptide Eye Drop in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 Peptide Eye Drop Market Overview
1.1 Product Definition
1.2 Peptide Eye Drop by Type
1.2.1 Global Peptide Eye Drop Market Value Comparison by Type (2024 VS 2031)
1.2.2 Acetyl Carnosine Eye Drops
1.2.3 Amiodopeptide Eye Drops
1.2.4 Ocular Aminopeptide Eye Drops
1.2.5 Glutathione Eye Drops
1.3 Peptide Eye Drop by Application
1.3.1 Global Peptide Eye Drop Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Eye Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Peptide Eye Drop Market Size Estimates and Forecasts
1.4.1 Global Peptide Eye Drop Revenue 2020-2031
1.4.2 Global Peptide Eye Drop Sales 2020-2031
1.4.3 Global Peptide Eye Drop Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Peptide Eye Drop Market Competition by Manufacturers
2.1 Global Peptide Eye Drop Sales Market Share by Manufacturers (2020-2025)
2.2 Global Peptide Eye Drop Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Peptide Eye Drop Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Peptide Eye Drop, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peptide Eye Drop, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peptide Eye Drop, Product Type & Application
2.7 Global Key Manufacturers of Peptide Eye Drop, Date of Enter into This Industry
2.8 Global Peptide Eye Drop Market Competitive Situation and Trends
2.8.1 Global Peptide Eye Drop Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peptide Eye Drop Players Market Share by Revenue
2.8.3 Global Peptide Eye Drop Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peptide Eye Drop Market Scenario by Region
3.1 Global Peptide Eye Drop Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Peptide Eye Drop Sales by Region: 2020-2031
3.2.1 Global Peptide Eye Drop Sales by Region: 2020-2025
3.2.2 Global Peptide Eye Drop Sales by Region: 2026-2031
3.3 Global Peptide Eye Drop Revenue by Region: 2020-2031
3.3.1 Global Peptide Eye Drop Revenue by Region: 2020-2025
3.3.2 Global Peptide Eye Drop Revenue by Region: 2026-2031
3.4 North America Peptide Eye Drop Market Facts & Figures by Country
3.4.1 North America Peptide Eye Drop Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Peptide Eye Drop Sales by Country (2020-2031)
3.4.3 North America Peptide Eye Drop Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peptide Eye Drop Market Facts & Figures by Country
3.5.1 Europe Peptide Eye Drop Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Peptide Eye Drop Sales by Country (2020-2031)
3.5.3 Europe Peptide Eye Drop Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peptide Eye Drop Market Facts & Figures by Region
3.6.1 Asia Pacific Peptide Eye Drop Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Peptide Eye Drop Sales by Region (2020-2031)
3.6.3 Asia Pacific Peptide Eye Drop Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Peptide Eye Drop Market Facts & Figures by Country
3.7.1 Latin America Peptide Eye Drop Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Peptide Eye Drop Sales by Country (2020-2031)
3.7.3 Latin America Peptide Eye Drop Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peptide Eye Drop Market Facts & Figures by Country
3.8.1 Middle East and Africa Peptide Eye Drop Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Peptide Eye Drop Sales by Country (2020-2031)
3.8.3 Middle East and Africa Peptide Eye Drop Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peptide Eye Drop Sales by Type (2020-2031)
4.1.1 Global Peptide Eye Drop Sales by Type (2020-2025)
4.1.2 Global Peptide Eye Drop Sales by Type (2026-2031)
4.1.3 Global Peptide Eye Drop Sales Market Share by Type (2020-2031)
4.2 Global Peptide Eye Drop Revenue by Type (2020-2031)
4.2.1 Global Peptide Eye Drop Revenue by Type (2020-2025)
4.2.2 Global Peptide Eye Drop Revenue by Type (2026-2031)
4.2.3 Global Peptide Eye Drop Revenue Market Share by Type (2020-2031)
4.3 Global Peptide Eye Drop Price by Type (2020-2031)
5 Segment by Application
5.1 Global Peptide Eye Drop Sales by Application (2020-2031)
5.1.1 Global Peptide Eye Drop Sales by Application (2020-2025)
5.1.2 Global Peptide Eye Drop Sales by Application (2026-2031)
5.1.3 Global Peptide Eye Drop Sales Market Share by Application (2020-2031)
5.2 Global Peptide Eye Drop Revenue by Application (2020-2031)
5.2.1 Global Peptide Eye Drop Revenue by Application (2020-2025)
5.2.2 Global Peptide Eye Drop Revenue by Application (2026-2031)
5.2.3 Global Peptide Eye Drop Revenue Market Share by Application (2020-2031)
5.3 Global Peptide Eye Drop Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hangzhou Guoguang Pharmaceutical
6.1.1 Hangzhou Guoguang Pharmaceutical Company Information
6.1.2 Hangzhou Guoguang Pharmaceutical Description and Business Overview
6.1.3 Hangzhou Guoguang Pharmaceutical Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hangzhou Guoguang Pharmaceutical Peptide Eye Drop Product Portfolio
6.1.5 Hangzhou Guoguang Pharmaceutical Recent Developments/Updates
6.2 Jiangsu Hengxin Pharmaceutical
6.2.1 Jiangsu Hengxin Pharmaceutical Company Information
6.2.2 Jiangsu Hengxin Pharmaceutical Description and Business Overview
6.2.3 Jiangsu Hengxin Pharmaceutical Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Jiangsu Hengxin Pharmaceutical Peptide Eye Drop Product Portfolio
6.2.5 Jiangsu Hengxin Pharmaceutical Recent Developments/Updates
6.3 Can-C
6.3.1 Can-C Company Information
6.3.2 Can-C Description and Business Overview
6.3.3 Can-C Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Can-C Peptide Eye Drop Product Portfolio
6.3.5 Can-C Recent Developments/Updates
6.4 Life Extension
6.4.1 Life Extension Company Information
6.4.2 Life Extension Description and Business Overview
6.4.3 Life Extension Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Life Extension Peptide Eye Drop Product Portfolio
6.4.5 Life Extension Recent Developments/Updates
6.5 Oclumed LLC
6.5.1 Oclumed LLC Company Information
6.5.2 Oclumed LLC Description and Business Overview
6.5.3 Oclumed LLC Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Oclumed LLC Peptide Eye Drop Product Portfolio
6.5.5 Oclumed LLC Recent Developments/Updates
6.6 OPKO Health
6.6.1 OPKO Health Company Information
6.6.2 OPKO Health Description and Business Overview
6.6.3 OPKO Health Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.6.4 OPKO Health Peptide Eye Drop Product Portfolio
6.6.5 OPKO Health Recent Developments/Updates
6.7 Eyeris Vision Care Pvt. Ltd.
6.7.1 Eyeris Vision Care Pvt. Ltd. Company Information
6.7.2 Eyeris Vision Care Pvt. Ltd. Description and Business Overview
6.7.3 Eyeris Vision Care Pvt. Ltd. Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Eyeris Vision Care Pvt. Ltd. Peptide Eye Drop Product Portfolio
6.7.5 Eyeris Vision Care Pvt. Ltd. Recent Developments/Updates
6.8 Shaanxi Berson Pharmaceutical
6.8.1 Shaanxi Berson Pharmaceutical Company Information
6.8.2 Shaanxi Berson Pharmaceutical Description and Business Overview
6.8.3 Shaanxi Berson Pharmaceutical Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shaanxi Berson Pharmaceutical Peptide Eye Drop Product Portfolio
6.8.5 Shaanxi Berson Pharmaceutical Recent Developments/Updates
6.9 Choseido Pharmaceutical
6.9.1 Choseido Pharmaceutical Company Information
6.9.2 Choseido Pharmaceutical Description and Business Overview
6.9.3 Choseido Pharmaceutical Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Choseido Pharmaceutical Peptide Eye Drop Product Portfolio
6.9.5 Choseido Pharmaceutical Recent Developments/Updates
6.10 Wuhan Wujing Pharmaceutical
6.10.1 Wuhan Wujing Pharmaceutical Company Information
6.10.2 Wuhan Wujing Pharmaceutical Description and Business Overview
6.10.3 Wuhan Wujing Pharmaceutical Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Wuhan Wujing Pharmaceutical Peptide Eye Drop Product Portfolio
6.10.5 Wuhan Wujing Pharmaceutical Recent Developments/Updates
6.11 DR Vitamin
6.11.1 DR Vitamin Company Information
6.11.2 DR Vitamin Description and Business Overview
6.11.3 DR Vitamin Peptide Eye Drop Sales, Revenue and Gross Margin (2020-2025)
6.11.4 DR Vitamin Peptide Eye Drop Product Portfolio
6.11.5 DR Vitamin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peptide Eye Drop Industry Chain Analysis
7.2 Peptide Eye Drop Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peptide Eye Drop Production Mode & Process Analysis
7.4 Peptide Eye Drop Sales and Marketing
7.4.1 Peptide Eye Drop Sales Channels
7.4.2 Peptide Eye Drop Distributors
7.5 Peptide Eye Drop Customer Analysis
8 Peptide Eye Drop Market Dynamics
8.1 Peptide Eye Drop Industry Trends
8.2 Peptide Eye Drop Market Drivers
8.3 Peptide Eye Drop Market Challenges
8.4 Peptide Eye Drop Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Peptide Eye Drop Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Peptide Eye Drop Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Peptide Eye Drop Market Competitive Situation by Manufacturers in 2024
Table 4. Global Peptide Eye Drop Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Peptide Eye Drop Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Peptide Eye Drop Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Peptide Eye Drop Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Peptide Eye Drop Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Peptide Eye Drop, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peptide Eye Drop, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peptide Eye Drop, Product Type & Application
Table 12. Global Key Manufacturers of Peptide Eye Drop, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peptide Eye Drop by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Eye Drop as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peptide Eye Drop Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Peptide Eye Drop Sales by Region (2020-2025) & (K Units)
Table 18. Global Peptide Eye Drop Sales Market Share by Region (2020-2025)
Table 19. Global Peptide Eye Drop Sales by Region (2026-2031) & (K Units)
Table 20. Global Peptide Eye Drop Sales Market Share by Region (2026-2031)
Table 21. Global Peptide Eye Drop Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Peptide Eye Drop Revenue Market Share by Region (2020-2025)
Table 23. Global Peptide Eye Drop Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Peptide Eye Drop Revenue Market Share by Region (2026-2031)
Table 25. North America Peptide Eye Drop Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Peptide Eye Drop Sales by Country (2020-2025) & (K Units)
Table 27. North America Peptide Eye Drop Sales by Country (2026-2031) & (K Units)
Table 28. North America Peptide Eye Drop Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Peptide Eye Drop Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Peptide Eye Drop Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Peptide Eye Drop Sales by Country (2020-2025) & (K Units)
Table 32. Europe Peptide Eye Drop Sales by Country (2026-2031) & (K Units)
Table 33. Europe Peptide Eye Drop Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Peptide Eye Drop Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Peptide Eye Drop Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Peptide Eye Drop Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Peptide Eye Drop Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Peptide Eye Drop Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Peptide Eye Drop Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide Eye Drop Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Peptide Eye Drop Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Peptide Eye Drop Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Peptide Eye Drop Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Peptide Eye Drop Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Peptide Eye Drop Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Peptide Eye Drop Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Peptide Eye Drop Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Peptide Eye Drop Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Peptide Eye Drop Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Peptide Eye Drop Sales (K Units) by Type (2020-2025)
Table 51. Global Peptide Eye Drop Sales (K Units) by Type (2026-2031)
Table 52. Global Peptide Eye Drop Sales Market Share by Type (2020-2025)
Table 53. Global Peptide Eye Drop Sales Market Share by Type (2026-2031)
Table 54. Global Peptide Eye Drop Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Peptide Eye Drop Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Peptide Eye Drop Revenue Market Share by Type (2020-2025)
Table 57. Global Peptide Eye Drop Revenue Market Share by Type (2026-2031)
Table 58. Global Peptide Eye Drop Price (US$/Unit) by Type (2020-2025)
Table 59. Global Peptide Eye Drop Price (US$/Unit) by Type (2026-2031)
Table 60. Global Peptide Eye Drop Sales (K Units) by Application (2020-2025)
Table 61. Global Peptide Eye Drop Sales (K Units) by Application (2026-2031)
Table 62. Global Peptide Eye Drop Sales Market Share by Application (2020-2025)
Table 63. Global Peptide Eye Drop Sales Market Share by Application (2026-2031)
Table 64. Global Peptide Eye Drop Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Peptide Eye Drop Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Peptide Eye Drop Revenue Market Share by Application (2020-2025)
Table 67. Global Peptide Eye Drop Revenue Market Share by Application (2026-2031)
Table 68. Global Peptide Eye Drop Price (US$/Unit) by Application (2020-2025)
Table 69. Global Peptide Eye Drop Price (US$/Unit) by Application (2026-2031)
Table 70. Hangzhou Guoguang Pharmaceutical Company Information
Table 71. Hangzhou Guoguang Pharmaceutical Description and Business Overview
Table 72. Hangzhou Guoguang Pharmaceutical Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Hangzhou Guoguang Pharmaceutical Peptide Eye Drop Product
Table 74. Hangzhou Guoguang Pharmaceutical Recent Developments/Updates
Table 75. Jiangsu Hengxin Pharmaceutical Company Information
Table 76. Jiangsu Hengxin Pharmaceutical Description and Business Overview
Table 77. Jiangsu Hengxin Pharmaceutical Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Jiangsu Hengxin Pharmaceutical Peptide Eye Drop Product
Table 79. Jiangsu Hengxin Pharmaceutical Recent Developments/Updates
Table 80. Can-C Company Information
Table 81. Can-C Description and Business Overview
Table 82. Can-C Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Can-C Peptide Eye Drop Product
Table 84. Can-C Recent Developments/Updates
Table 85. Life Extension Company Information
Table 86. Life Extension Description and Business Overview
Table 87. Life Extension Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Life Extension Peptide Eye Drop Product
Table 89. Life Extension Recent Developments/Updates
Table 90. Oclumed LLC Company Information
Table 91. Oclumed LLC Description and Business Overview
Table 92. Oclumed LLC Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Oclumed LLC Peptide Eye Drop Product
Table 94. Oclumed LLC Recent Developments/Updates
Table 95. OPKO Health Company Information
Table 96. OPKO Health Description and Business Overview
Table 97. OPKO Health Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. OPKO Health Peptide Eye Drop Product
Table 99. OPKO Health Recent Developments/Updates
Table 100. Eyeris Vision Care Pvt. Ltd. Company Information
Table 101. Eyeris Vision Care Pvt. Ltd. Description and Business Overview
Table 102. Eyeris Vision Care Pvt. Ltd. Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Eyeris Vision Care Pvt. Ltd. Peptide Eye Drop Product
Table 104. Eyeris Vision Care Pvt. Ltd. Recent Developments/Updates
Table 105. Shaanxi Berson Pharmaceutical Company Information
Table 106. Shaanxi Berson Pharmaceutical Description and Business Overview
Table 107. Shaanxi Berson Pharmaceutical Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Shaanxi Berson Pharmaceutical Peptide Eye Drop Product
Table 109. Shaanxi Berson Pharmaceutical Recent Developments/Updates
Table 110. Choseido Pharmaceutical Company Information
Table 111. Choseido Pharmaceutical Description and Business Overview
Table 112. Choseido Pharmaceutical Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Choseido Pharmaceutical Peptide Eye Drop Product
Table 114. Choseido Pharmaceutical Recent Developments/Updates
Table 115. Wuhan Wujing Pharmaceutical Company Information
Table 116. Wuhan Wujing Pharmaceutical Description and Business Overview
Table 117. Wuhan Wujing Pharmaceutical Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Wuhan Wujing Pharmaceutical Peptide Eye Drop Product
Table 119. Wuhan Wujing Pharmaceutical Recent Developments/Updates
Table 120. DR Vitamin Company Information
Table 121. DR Vitamin Description and Business Overview
Table 122. DR Vitamin Peptide Eye Drop Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. DR Vitamin Peptide Eye Drop Product
Table 124. DR Vitamin Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Peptide Eye Drop Distributors List
Table 128. Peptide Eye Drop Customers List
Table 129. Peptide Eye Drop Market Trends
Table 130. Peptide Eye Drop Market Drivers
Table 131. Peptide Eye Drop Market Challenges
Table 132. Peptide Eye Drop Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report


List of Figures
Figure 1. Product Picture of Peptide Eye Drop
Figure 2. Global Peptide Eye Drop Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide Eye Drop Market Share by Type: 2024 & 2031
Figure 4. Acetyl Carnosine Eye Drops Product Picture
Figure 5. Amiodopeptide Eye Drops Product Picture
Figure 6. Ocular Aminopeptide Eye Drops Product Picture
Figure 7. Glutathione Eye Drops Product Picture
Figure 8. Global Peptide Eye Drop Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Peptide Eye Drop Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Eye Clinic
Figure 12. Pharmacy
Figure 13. Other
Figure 14. Global Peptide Eye Drop Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Peptide Eye Drop Market Size (2020-2031) & (US$ Million)
Figure 16. Global Peptide Eye Drop Sales (2020-2031) & (K Units)
Figure 17. Global Peptide Eye Drop Average Price (US$/Unit) & (2020-2031)
Figure 18. Peptide Eye Drop Report Years Considered
Figure 19. Peptide Eye Drop Sales Share by Manufacturers in 2024
Figure 20. Global Peptide Eye Drop Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Peptide Eye Drop Players: Market Share by Revenue in Peptide Eye Drop in 2024
Figure 22. Peptide Eye Drop Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Peptide Eye Drop Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Peptide Eye Drop Sales Market Share by Country (2020-2031)
Figure 25. North America Peptide Eye Drop Revenue Market Share by Country (2020-2031)
Figure 26. United States Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Peptide Eye Drop Sales Market Share by Country (2020-2031)
Figure 29. Europe Peptide Eye Drop Revenue Market Share by Country (2020-2031)
Figure 30. Germany Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Peptide Eye Drop Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Peptide Eye Drop Revenue Market Share by Region (2020-2031)
Figure 37. China Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Peptide Eye Drop Sales Market Share by Country (2020-2031)
Figure 45. Latin America Peptide Eye Drop Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Peptide Eye Drop Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Peptide Eye Drop Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Peptide Eye Drop Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Peptide Eye Drop by Type (2020-2031)
Figure 55. Global Revenue Market Share of Peptide Eye Drop by Type (2020-2031)
Figure 56. Global Peptide Eye Drop Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Peptide Eye Drop by Application (2020-2031)
Figure 58. Global Revenue Market Share of Peptide Eye Drop by Application (2020-2031)
Figure 59. Global Peptide Eye Drop Price (US$/Unit) by Application (2020-2031)
Figure 60. Peptide Eye Drop Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies